Fetal Fractures in an Infant with Maternal Ehlers-Danlos Syndrome, CCDC134 Pathogenic Mutation and a Negative Genetic Test for Osteogenesis Imperfecta

Intrauterine fractures are a rare clinical finding caused by abnormal early-life osteogenesis. In this case report, we reported a male infant with twenty-three intrauterine/fetal fractures resembling osteogenesis imperfecta and tested negative for COL1A1 and COL1A2 mutations. The infant’s mother had Ehlers–Danlos syndrome, hypermobility type. Whole-genome sequencing revealed that there were no pathologic mutations previously documented to be associated with intrauterine fracture. Genetic mutations reported to be associated with fragility fractures were identified. These include the pathogenic homozygous mutation in the CCDC134 gene. Other genetic variants that might be responsible for variable expressivity of the skeletal manifestation include the homozygous variants of the genes CCDC134, COL15A1 and ZFPM1, and the heterozygous variants of the genes MYH3, BCHE, AUTS2. This is the first reported case of in utero fractures, that was confirmed by X-ray after birth, in an infant who had no genetic evidence for osteogenesis imperfecta, had a homozygous pathogenic mutation of an osteogenesis gene and whose mother had Ehlers-Danlos syndrome hypermobility type. Therefore, we have identified a new genetic cause for in utero fractures. If after birth, this infant were found to have these fractures in various stages of healing with a negative genetic test for osteogenesis imperfecta he would have been misdiagnosed as due to nonaccidental trauma.

[1]  Tanya S. Hinds,et al.  Genetic causes of fractures and subdural hematomas: fact versus fiction , 2021, Pediatric Radiology.

[2]  Jeannette M. Perez-Rossello,et al.  Ehlers–Danlos syndrome: what the radiologist needs to know , 2021, Pediatric Radiology.

[3]  T. Mazza,et al.  Whole Exome Sequencing Reveals a Novel AUTS2 In-Frame Deletion in a Boy with Global Developmental Delay, Absent Speech, Dysmorphic Features, and Cerebral Anomalies , 2021, Genes.

[4]  N. Robin,et al.  Medical genetics, expert medical testimony, and suspected child abuse cases: a call for evidence-based standards in clinic and the courtroom. , 2020, Current opinion in pediatrics.

[5]  M. Holick,et al.  Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility. , 2020, Current opinion in pediatrics.

[6]  D. Judge,et al.  Hypermobile Ehlers‐Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes , 2020, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  V. Cormier-Daire,et al.  Homozygous Loss‐of‐Function Mutations in CCDC134 Are Responsible for a Severe Form of Osteogenesis Imperfecta , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  W. Reardon,et al.  COL1‐related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers‐Danlos syndrome overlap , 2019, Clinical genetics.

[9]  I. Berindan‐Neagoe,et al.  A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer , 2019, Cancers.

[10]  D. Deyle,et al.  Fracture incidence in Ehlers-Danlos syndrome - A population-based case-control study. , 2019, Child abuse & neglect.

[11]  Jae-Hyuck Shim,et al.  The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis , 2019, International journal of molecular sciences.

[12]  M. Ritelli,et al.  Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts , 2019, PloS one.

[13]  S. Sauer,et al.  Loss of the Hematopoietic Stem Cell Factor GATA2 in the Osteogenic Lineage Impairs Trabecularization and Mechanical Strength of Bone , 2018, Molecular and Cellular Biology.

[14]  F. Glorieux,et al.  Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta , 2017, Osteoporosis International.

[15]  C. Manferdini,et al.  Collagen type XV and the ‘osteogenic status’ , 2017, Journal of cellular and molecular medicine.

[16]  J. Belmont,et al.  The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[17]  D. Nickerson,et al.  A postnatal role for embryonic myosin revealed by MYH3 mutations that alter TGFβ signaling and cause autosomal dominant spondylocarpotarsal synostosis , 2017, Scientific Reports.

[18]  M. Holick,et al.  Multiple fractures in infants who have Ehlers-Danlos/hypermobility syndrome and or vitamin D deficiency: A case series of 72 infants whose parents were accused of child abuse and neglect , 2017, Dermato-endocrinology.

[19]  P. Calzavara-Pinton,et al.  High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome. , 2016, Bone.

[20]  N. Shur,et al.  Genetic differentials of child abuse: Is your case rare or real? , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[21]  L. Dürselen,et al.  Bone status of adult female butyrylcholinesterase gene-deficient mice. , 2015, International immunopharmacology.

[22]  Carlo Reggiani,et al.  Developmental myosins: expression patterns and functional significance , 2015, Skeletal Muscle.

[23]  M. Ritelli,et al.  Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers‐danlos syndrome hypermobility type compared to other heritable connective tissue disorders , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[24]  Z. Karamizadeh,et al.  Cardiovascular Involvement in Children with Osteogenesis Imperfecta , 2013, Iranian journal of pediatrics.

[25]  Joseph A. Morgan,et al.  Prenatal Diagnosis and Management of Intrauterine Fracture , 2010, Obstetrical & gynecological survey.

[26]  D. Sillence,et al.  The differential diagnosis of children with joint hypermobility: a review of the literature , 2008, Pediatric rheumatology online journal.

[27]  Y. Lu,et al.  CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK , 2007, Cellular and Molecular Life Sciences.

[28]  M. Bamshad,et al.  Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome , 2006, Nature Genetics.

[29]  P. Beighton,et al.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). , 1998, American journal of medical genetics.